Abstract
Relapse rates appear to be relatively high in the period of time following the cessation of an acute course of rTMS treatment. A number of strategies can be explored to minimise relapse rates. These include the provision of appropriate ongoing antidepressant medication, possibly combined with a mood stabiliser such as lithium. Specific forms of psychotherapy are also likely to have relapse prevention potential although these have not been systematically evaluated following rTMS treatment. A number of methods for the provision of rTMS maintenance have been proposed, although only limited data has explored the efficacy of these to date. Patients who have responded well to rTMS treatment and subsequently relapsed appear to have a high likelihood of responding to a subsequent course of rTMS treatment with no accumulation of risks or side effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Grunhaus L, Dolberg O, Lustig M (1995) Relapse and recurrence following a course of ECT: reasons for concern and strategies for further investigation. J Psychiatr Res 29(3):165–172, Epub 1995/05/01
Tew JD Jr, Mulsant BH, Haskett RF, Joan P, Begley AE, Sackeim HA (2007) Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. Ann Clin Psychiatry 19(1):1–4, Epub 2007/04/25
Dannon PN, Dolberg OT, Schreiber S, Grunhaus L (2002) Three and six-month outcome Âfollowing courses of either ECT or rTMS in a population of severely depressed individuals – preliminary report. Biol Psychiatry 51(8):687–690
Cohen RB, Boggio PS, Fregni F (2009) Risk factors for relapse after remission with repetitive transcranial magnetic stimulation for the treatment of depression. Depress Anxiety 26(7):682–688
Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM et al (2010) Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimul 3(4):187–199, Epub 2010/10/23
Robinson RG, Tenev V, Jorge RE (2009) Citalopram for continuation therapy after repetitive transcranial magnetic stimulation in vascular depression. Am J Geriatr Psychiatry 17(8):682–687
Dell’osso B, D’Urso N, Castellano F, Ciabatti M, Altamura AC (2011) Long-term efficacy after acute augmentative repetitive transcranial magnetic stimulation in bipolar depression: a 1-year follow-up study. J ECT 27(2):141–144, Epub 2010/10/23
van den Broek WW, Birkenhager TK, Mulder PG, Bruijn JA, Moleman P (2006) Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry 67(2):263–268, Epub 2006/03/29
Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM et al (2001) Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 285(10):1299–1307, Epub 2001/03/20
Rehor G, Conca A, Schlotter W, Vonthein R, Bork S, Bode R et al (2009) Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis. Neuropsychiatr 23(3):157–163, Epub 2009/08/26. Ruckfallraten innerhalb von 6 Monaten nach erfolgreicher EKT-Eine naturalistische prospektive Fremd- und Selbstbeurteilungsanalyse
Gloaguen V, Cottraux J, Cucherat M, Blackburn IM (1998) A meta-analysis of the effects of cognitive therapy in depressed patients. J Affect Disord 49(1):59–72, Epub 1998/05/09
Blackburn IM, Eunson KM, Bishop S (1986) A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord 10(1):67–75, Epub 1986/01/01
Evans MD, Hollon SD, DeRubeis RJ, Piasecki JM, Grove WM, Garvey MJ et al (1992) Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry 49(10):802–808, Epub 1992/10/01
Simons AD, Murphy GE, Levine JL, Wetzel RD (1986) Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry 43(1):43–48, Epub 1986/01/01
Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S (2004) Six-year outcome of cognitive behavior therapy for prevention of recurrent depression. Am J Psychiatry 161(10):1872–1876, Epub 2004/10/07
Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R et al (1999) Prevention of relapse in residual depression by cognitive therapy: a controlled trial. Arch Gen Psychiatry 56(9):829–835, Epub 2003/07/30
Paykel ES, Scott J, Cornwall PL, Abbott R, Crane C, Pope M et al (2005) Duration of relapse prevention after cognitive therapy in residual depression: follow-up of controlled trial. Psychol Med 35(1):59–68, Epub 2005/04/22
Beck J (1996) Cognitive therapy: basics and beyond. Guilford Press, New York
Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA (2000) Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 68(4):615–623, Epub 2000/08/31
Ma SH, Teasdale JD (2004) Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol 72(1):31–40, Epub 2004/02/06
Chiesa A, Serretti A (2011) Mindfulness based cognitive therapy for psychiatric disorders: a systematic review and meta-analysis. Psychiatry Res 187(3):441–453, Epub 2010/09/18
Kuyken W, Byford S, Taylor RS, Watkins E, Holden E, White K et al (2008) Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol 76(6):966–978, Epub 2008/12/03
Kuyken W, Watkins E, Holden E, White K, Taylor RS, Byford S et al (2010) How does mindfulness-based cognitive therapy work? Behav Res Ther 48(11):1105–1112, Epub 2010/09/03
Fenton L, Fasula M, Ostroff R, Sanacora G (2006) Can cognitive behavioral therapy reduce relapse rates of depression after ECT? A preliminary study. J ECT 22(3):196–198, Epub 2006/09/08
Isserles M, Rosenberg O, Dannon P, Levkovitz Y, Kotler M, Deutsch F et al (2011) Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcome. J Affect Disord 128(3):235–242, Epub 2010/07/29
O’Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC (2005) Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 66(12):1524–1528
Li X, Nahas Z, Anderson B, Kozel FA, George MS (2004) Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety 20(2):98–100
Demirtas-Tatlidede A, Mechanic-Hamilton D, Press DZ, Pearlman C, Stern WM, Thall M et al (2008) An open-label, prospective study of repetitive transcranial magnetic stimulation (rTMS) in the long-term treatment of refractory depression: reproducibility and duration of the antidepressant effect in medication-free patients. J Clin Psychiatry 69(6):930–934
Fitzgerald PB, Benitez J, de Castella AR, Brown TL, Daskalakis ZJ, Kulkarni J (2006) Naturalistic study of the use of transcranial magnetic stimulation in the treatment of depressive relapse. Aust N Z J Psychiatry 40(9):764–768, Epub 2006/08/17
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fitzgerald, P.B., Daskalakis, Z.J. (2013). Maintenance and Continuation Treatment. In: Repetitive Transcranial Magnetic Stimulation Treatment for Depressive Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-36467-9_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-36467-9_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-36466-2
Online ISBN: 978-3-642-36467-9
eBook Packages: MedicineMedicine (R0)